FLORENCE, Italy, Sept. 2, 2025 /PRNewswire/ — Medical Horizons S.r.l., (medicalhorizons.it) a leading distributor of Artificial Intelligence (AI) solutions for healthcare, today announced an exclusive distribution agreement with Bowhead Health Inc.(bowheadhealth.com), a Canadian innovator in secure health data management and AI-powered clinical trial matching.
Under this agreement, Medical Horizons becomes the exclusive partner for Bowhead Health in Italy, Turkey, and Cyprus, expanding access to advanced technologies that improve clinical trial recruitment, optimize research workflows, and strengthen hospital and research institute capabilities across the region.
Addressing Healthcare’s Urgent Needs
Healthcare systems worldwide face growing challenges from workforce shortages and rising clinical demands. Artificial intelligence is increasingly recognized as a critical tool to help address these pressures, enabling hospitals and researchers to deliver faster, more personalized care.
“Manual clinical trial matching is slow, burdensome, and often misses the genomic details that matter most,” said Francisco Diaz-Mitoma, CEO of Bowhead Health Inc. “Our platform allows hospitals to scan global and local trial databases instantly, helping them connect patients with the right therapies far more efficiently.”
Bowhead’s AI-driven technology reduces time spent on manual searches, simplifies workflows, and provides confidence for both researchers and patients, accelerating progress toward personalized medicine.
A Strategic Expansion for Medical Horizons
For Medical Horizons, the partnership marks a continuation of its mission to bring best-in-class AI technologies to European healthcare providers.
“This collaboration represents a decisive step in our strategy to deliver practical, high-impact AI solutions,” said Guido Osti, CEO of Medical Horizons. “Bowhead Health has developed a unique platform that combines secure health data management, artificial intelligence, and clinical research. We are proud to guide their expansion in Italy, Turkey, and Cyprus.”
Bowhead Health Inc.
Based in Ottawa, Canada, Bowhead Health has developed a secure digital ecosystem that integrates:
- An AI-powered trial matching engine for personalized patient recruitment.
- A de-identified health data platform compliant with GDPR, HIPAA, and global security standards.
- Collaborative digital flows connecting patients, hospitals, researchers, and pharmaceutical companies.
Bowhead Health is currently validating its technology with leading hospitals in Canada, Europe, India, and the United States, with strong early results.
Medical Horizons S.r.l.
Headquartered in Florence, Medical Horizons is Italy’s leading distributor of AI healthcare technologies, with a proven track record of supporting hospitals of excellence in adopting next-generation solutions. The company provides market entry strategies, financial guidance, KOL engagement, and ongoing customer support to ensure long-term adoption and impact.
Medical Horizons has successfully introduced innovative AI platforms from companies such as Tempus Pixel, Cortechs.ai, AZmed, and iCAD into the Italian healthcare ecosystem, and collaborates closely with institutions such as the Campus Bio-Medico University Hospital of Rome.
Contact:
Francisco Diaz-Mitoma
+1 310 760 6569
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/medical-horizons-and-bowhead-health-inc-announce-exclusive-partnership-to-bring-ai-powered-clinical-research-solutions-to-italy-turkey-and-cyprus-302542267.html
SOURCE Bowhead Health Inc.
